SRPK1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.557000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.216200E-01
Normal-vs-Stage2
1.276740E-03
Normal-vs-Stage3
9.159600E-01
Normal-vs-Stage4
1.482170E-01
Stage1-vs-Stage2
6.026800E-01
Stage1-vs-Stage3
6.222200E-01
Stage1-vs-Stage4
1.797810E-01
Stage2-vs-Stage3
2.748600E-01
Stage2-vs-Stage4
4.090100E-02
Stage3-vs-Stage4
1.476840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.279800E-01
Normal-vs-AfricanAmerican
2.177200E-01
Normal-vs-Asian
8.220200E-02
Caucasian-vs-AfricanAmerican
5.193600E-01
Caucasian-vs-Asian
2.629800E-01
AfricanAmerican-vs-Asian
5.841200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.066200E-01
Normal-vs-Female
9.840100E-04
Male-vs-Female
7.256000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.828000E-01
Normal-vs-Age(41-60Yrs)
3.219100E-04
Normal-vs-Age(61-80Yrs)
3.435400E-03
Normal-vs-Age(81-100Yrs)
2.666200E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.510000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.573400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.516200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.442000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.173000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.630800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.746800E-01
Normal-vs-Daily Drinker
7.688800E-01
Normal-vs-Weekly Drinker
1.691630E-01
Normal-vs-Occasional Drinker
1.167030E-01
Normal-vs-Social Drinker
3.183400E-01
Non Drinker-vs-Daily Drinker
8.098400E-02
Non Drinker-vs-Weekly Drinker
5.431400E-01
Non Drinker-vs-Occasional Drinker
3.286600E-01
Non Drinker-vs-Social Drinker
4.113600E-01
Daily Drinker-vs-Weekly Drinker
4.119800E-01
Daily Drinker-vs-Occasional Drinker
1.354050E-02
Daily Drinker-vs-Social Drinker
3.786400E-01
Weekly Drinker-vs-Occasional Drinker
1.834600E-01
Weekly Drinker-vs-Social Drinker
9.225400E-01
Occasional Drinker-vs-Social Drinker
8.390300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.723400E-01
Normal-vs-Grade 2
3.142200E-02
Normal-vs-Grade 3
3.604100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.295600E-01
Grade 1-vs-Grade 3
2.249000E-01
Grade 1-vs-Grade 4
3.723400E-01
Grade 2-vs-Grade 3
3.228800E-01
Grade 2-vs-Grade 4
3.142200E-02
Grade 3-vs-Grade 4
3.604100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.345200E-01
Normal-vs-NonDiabetic
1.284010E-03
Diabetic-vs-NonDiabetic
3.746600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.032600E-01
Normal-vs-NoPancreatitis
2.555100E-03
Pancreatitis-vs-NoPancreatitis
9.060200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.400020E-03
Normal-vs-N1
1.063380E-03
N0-vs-N1
8.972600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.642300E-04
Normal-vs-TP53-NonMutant
3.448000E-01
TP53-Mutant-vs-TP53-NonMutant
4.026500E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
